HONG KONG -- Inside a glass jar, a piece of cardiac tissue no bigger than a thumbnail pulsates to its own beat. The tiny organ's creator, Medera Biopharmaceutical, hopes that this powerful tool can reshape how drugs are tested and dramatically speed up the time it takes to bring them to market.
Biotechnology
Hong Kong biotech startup Medera bets on 'heart in a jar'
Company aims to cut drug development time and costs by replacing animal testing
